Literature DB >> 15490183

[Ischemia and hypoxia. An attempt to explain the different rates of retinal ganglion cell death in glaucoma].

K-G Schmidt1, L E Pillunat, N N Osborne.   

Abstract

In hypoxic or ischemic states, the receptors of the ganglion cells are overstimulated by release of neurotransmitters. Glutamate and GABA (gamma-aminobutyric acid) are the decisive neurotransmitters in the retina. It is presumed that the extent of cell death depends on the degree of depolarization, which in turn is determined by the amount of excitatory (glutamate) or inhibitory (GABA) receptors of the corresponding ganglion cell. The assumption is that the receptor profile of the individual ganglion cells determines the sensitivity of these cells to hypoxia or ischemia, i.e., the time up to cell death, and thus represents the underlying cause of the different rates of cell death in primary chronic open-angle glaucoma. Research on this receptor profile could be of pivotal importance for the approach to neuroprotective treatment of primary chronic open-angle glaucoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15490183     DOI: 10.1007/s00347-004-1131-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  34 in total

1.  Short posterior ciliary artery, central retinal artery, and choroidal hemodynamics in brimonidine-treated primary open-angle glaucoma patients.

Authors:  Karl-Georg Schmidt; Volker Klingmüller; Scott M Gouveia; Neville N Osborne; Lutz E Pillunat
Journal:  Am J Ophthalmol       Date:  2003-12       Impact factor: 5.258

2.  Ca2+-independent excitotoxic neurodegeneration in isolated retina, an intact neural net: a role for Cl- and inhibitory transmitters.

Authors:  Q Chen; J W Olney; P D Lukasiewicz; T Almli; C Romano
Journal:  Mol Pharmacol       Date:  1998-03       Impact factor: 4.436

Review 3.  Techniques for examining neuroprotective drugs in vivo.

Authors:  A R Green; A J Cross
Journal:  Int Rev Neurobiol       Date:  1997       Impact factor: 3.230

4.  Immunocytochemical localization of dopamine D1 receptors in the retina of mammals.

Authors:  J Nguyen-Legros; A Simon; I Caillé; B Bloch
Journal:  Vis Neurosci       Date:  1997 May-Jun       Impact factor: 3.241

5.  Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells.

Authors:  Y Otori; J Y Wei; C J Barnstable
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-05       Impact factor: 4.799

Review 6.  Structure and function of the NMDA receptor channel.

Authors:  H Mori; M Mishina
Journal:  Neuropharmacology       Date:  1995-10       Impact factor: 5.250

7.  Topical carbonic anhydrase inhibition increases ocular pulse amplitude in high tension primary open angle glaucoma.

Authors:  K G Schmidt; A von Rückmann; L E Pillunat
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

8.  Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma.

Authors:  E B Dreyer; D Zurakowski; R A Schumer; S M Podos; S A Lipton
Journal:  Arch Ophthalmol       Date:  1996-03

9.  Ocular perfusion pressures in different types of glaucoma.

Authors:  L E Pillunat; R Stodtmeister; R Marquardt; A Mattern
Journal:  Int Ophthalmol       Date:  1989-01       Impact factor: 2.031

Review 10.  Traumatic optic neuropathy.

Authors:  K D Steinsapir; R A Goldberg
Journal:  Surv Ophthalmol       Date:  1994 May-Jun       Impact factor: 6.048

View more
  7 in total

1.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

2.  Inhalative preconditioning with hydrogen sulfide attenuated apoptosis after retinal ischemia/reperfusion injury.

Authors:  Julia Biermann; Wolf A Lagrèze; Nils Schallner; Christian I Schwer; Ulrich Goebel
Journal:  Mol Vis       Date:  2011-05-07       Impact factor: 2.367

3.  Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma.

Authors:  Miin Roh; Yan Zhang; Yusuke Murakami; Aristomenis Thanos; Sung Chul Lee; Demetrios G Vavvas; Larry I Benowitz; Joan W Miller
Journal:  PLoS One       Date:  2012-07-03       Impact factor: 3.240

4.  Argon inhalation attenuates retinal apoptosis after ischemia/reperfusion injury in a time- and dose-dependent manner in rats.

Authors:  Felix Ulbrich; Nils Schallner; Mark Coburn; Torsten Loop; Wolf Alexander Lagrèze; Julia Biermann; Ulrich Goebel
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

5.  Proteomic Analysis of Various Rat Ocular Tissues after Ischemia-Reperfusion Injury and Possible Relevance to Acute Glaucoma.

Authors:  Hsin-Yi Chen; Hsiu-Chuan Chou; Shing-Jyh Chang; En-Chi Liao; Yi-Ting Tsai; Yu-Shan Wei; Ji-Min Li; Li-Hsun Lin; Meng-Wei Lin; Ying-Jen Chen; Yu-Sheng Chen; Chih-Chun Lin; Yi-Shiuan Wang; Mei-Lan Ko; Hong-Lin Chan
Journal:  Int J Mol Sci       Date:  2017-02-05       Impact factor: 5.923

6.  Neurodegenerative diseases of the retina and potential for protection and recovery.

Authors:  K-G Schmidt; H Bergert; R H W Funk
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

7.  The cellular and compartmental profile of mouse retinal glycolysis, tricarboxylic acid cycle, oxidative phosphorylation, and ~P transferring kinases.

Authors:  Elda M Rueda; Jerry E Johnson; Anand Giddabasappa; Anand Swaroop; Matthew J Brooks; Irena Sigel; Shawnta Y Chaney; Donald A Fox
Journal:  Mol Vis       Date:  2016-07-23       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.